Head of the Department: Head of the Laboratory: Due to its nature, psoriasis has a negative impact on the quality of life of patients.
Therefore, the choice of an appropriate and individually tailored treatment controlling the symptoms of the disorder is necessary and continues to be a challenge for dermatologists.
Therapeutic modalities in psoriasis should on the link hand action effective and on the other hand present a good safety profile. Methotrexate MTX is one of treatment options for psoriasis and action be administered psoriasis medication methotrexate in psoriasis-mechanism of action as monotherapy or in combination schemes. The paper presents the current state of knowledge about the possible treatment of psoriatic patients psoriasis medication MTX according to contemporary methotrexate psoriasis-mechanism.
The substance inhibits psoriasis medication methotrexate in psoriasis-mechanism of action reductase — an enzyme responsible for the reduction of dihydrofolic acid to tetrahydrofolic acid. Aminopterin was first used in the treatment of psoriasis and rheumatoid arthritis in [ 1 ].
At present, the drug is indicated for the treatment of practically all forms of moderate or severe psoriasis, including psoriatic arthritis [ 2 ]. Methotrexate has antiinflammatory, antiproliferative and immunosuppressive properties.
As mentioned above, the drug has a role in inhibiting dihydrofolate reductase DHFR and, therefore, psoriasis medication methotrexate in psoriasis-mechanism of action the psoriasis medication methotrexate in psoriasis-mechanism of action psoriasis medication methotrexate in psoriasis-mechanism of action folic acid. This visit web page to the inhibition of /lasix-cause-kidney-failure-end-stage.html activity of thymidylate synthase which is a necessary component for the synthesis of purines and pyrimidines, and thus for the click at this page of DNA.
The interference in that pathway is known to take place during the S-phase of the cell cycle, which causes the inhibition of growth and cell death apoptosis [ continue reading ]. By inhibiting DNA synthesis, MTX limits epithelial hyperplasia, reinforces the apoptosis of activated T cells, and inhibits the chemotaxis of neutrophils [ 4 ].
The exact mechanism of action of MTX in psoriasis vulgaris still click the following article unclear. Aside from antiproliferative and immunomodulatory actions, other possible pathways require detailed clarification. For MTX used in the treatment of rheumatoid arthritis, the psoriasis medication methotrexate in psoriasis-mechanism of action of DHFR inhibition described above does not appear to be the primary one. Instead, the mechanism is likely to comprise a number of pathways including inhibition of the activity of enzymes involved in the metabolism of purines leading to the accumulation of adenosinesuppression of T cell activation, decrease in the expression of intercellular adhesion psoriasis medication methotrexate in psoriasis-mechanism of action by T cells, increase in CD95 sensitivity of stimulated T cells, and suppression of the activity of methyltransferase with all the consequences of the process [ 5 ].
Administered parenterally, MTX is almost completely absorbed. psoriasis medication methotrexate in psoriasis-mechanism of action
After intramuscular injection, peak concentrations are achieved in 30 to psoriasis-mechanism min. Following oral administration and absorption of the drug, it becomes partially inactivated action the gastrointestinal tract and in the liver, which means that its bioavailability is low. The pleural psoriasis medication methotrexate CSF penetration of MTX is slow, so that the peak concentration is 30 times lower than the serum level.
The pharmacokinetic characteristics of MTX depend on the route of administration oral, subcutaneous, intramuscular, intravenous. Following oral administration, the drug is absorbed immediately but not completely the absorption is ca. After injection, MTX is absorbed immediately and completely, achieving /buspar-causing-anxiety-efficacy.html blood serum concentrations.
It needs to be stressed that there are virtually no differences in the bioavailability of MTX between the subcutaneous psoriasis medication methotrexate in psoriasis-mechanism of action intramuscular routes.
2018 ©